(Bio)pharma companies and medical device manufacturers are facing rapidly changing market conditions. The industry environment is characterized by more and more regulations, tougher market requirements as well as increasing pricing pressure from health insurers and health consumers.

Race for innovation

Globalization of the entire value chain, the rise of new competitors, pharmerging markets as well as an increasingly tough race at the innovation front to replace products running out of patent protection put pharma companies under heavy pressure. The convergence of healthcare, nanotechnology and digitization puts in question current business models, structures and processes.

Focus on the patient

However, despite this increasingly volatile and complex environment, companies have to meet their core mission: to provide medication to the patient – in a fast, safe and reliable manner. CAMELOT understands these challenges and helps life sciences companies build excellent patient-centric value chains that are agile without jeopardizing profitability.


Dr. Josef Packowski
Dr. Josef Packowski
Managing Partner

Connected supply chain

Find out how to build an end-to-end digital supply chain operating model in our latest case study.

Read more

Topics we particularly address:

  • Reducing complexity through supply chain segmentation
  • Distribution network optimization
  • Demand Driven LEAN SCM – synchronized and stabilized fulfilment of customer demand to tackle volatility and complexity
  • Operational excellence
  • Master data governance

Selected industry references:


In light of the increasingly complex and volatile market environment, traditional supply chains are outdated. The future belongs to differentiated, digitized and patient-centric supply chains creating added value for the patient.
Dr. Josef Packowski, Managing Partner